AIM-Harvard/TrialPanorama-filtered huggingface dataset:
Study 17684066 — intervention group
Group type: EXPERIMENTAL
Intervention: Left univentricular (LUV) pacing
Number of subjects: 18
Study 15248217 — intervention group
Group type: EXPERIMENTAL
Intervention: Intermediate dose of parenteral methotrexate (15 mg/m(2)/week)
Number of subjects: 133
Study 15248217 — intervention group
Group type: COMPARATOR
Intervention: Higher dose of parenteral methotrexate (30 mg/m(2)/week)
Number of subjects: 133
Study 12324294 — intervention group
Group type: EXPERIMENTAL
Intervention: Zinc (20 mg/d for infants, 40 mg/d for older children)
Number of subjects: 1087
Study 12324294 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 1087
Study 9852724 — intervention group
Group type: EXPERIMENTAL
Intervention: Total Parenteral Nutrition (TPN)
Number of subjects: 28
Study 9852724 — intervention group
Group type: EXPERIMENTAL
Intervention: Elemental Diet (ED)
Number of subjects: 28
Study 9852724 — intervention group
Group type: COMPARATOR
Intervention: Polymeric Diet (PD)
Number of subjects: 28
Study 8207189 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal sterile barrier precautions (mask, cap, sterile gloves, gown, and large drape)
Number of subjects: 343
Study 8207189 — intervention group
Group type: COMPARATOR
Intervention: Control precautions (sterile gloves and small drape only)
Number of subjects: 343
Study 8207189 — intervention group
Group type: EXPERIMENTAL
Intervention: Maximal sterile barrier precautions
Number of subjects: 343
Study 2590267 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg theophylline administered at 8 a.m.
Number of subjects: 10
Study 2590267 — intervention group
Group type: COMPARATOR
Intervention: 800 mg theophylline administered at 8 p.m.
Number of subjects: 10
Study 2590267 — intervention group
Group type: EXPERIMENTAL
Intervention: 800 mg theophylline administered at 8 a.m. and 8 p.m.
Number of subjects: 10
Study 31793032 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized extracorporeal biofeedback device for pelvic floor muscle training (PFMT)
Number of subjects: 84
Study 31793032 — intervention group
Group type: COMPARATOR
Intervention: Control group (standard care without biofeedback device)
Number of subjects: 84
Study 31793032 — intervention group
Group type: EXPERIMENTAL
Intervention: Personalized extracorporeal biofeedback device for PFMT
Number of subjects: 84
Study 26506570 — intervention group
Group type: EXPERIMENTAL
Intervention: JB01-BD (anti-HPV biological dressing)
Number of subjects: 77
Study 26506570 — intervention group
Group type: COMPARATOR
Intervention: Non-treatment group
Number of subjects: 77
Study 26279130 — intervention group
Group type: EXPERIMENTAL
Intervention: Switching to bupropion-SR
Number of subjects: 0
Study 26279130 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmenting with bupropion-SR
Number of subjects: 0
Study 26279130 — intervention group
Group type: EXPERIMENTAL
Intervention: Augmenting with aripiprazole
Number of subjects: 0
Study 26279130 — intervention group
Group type: COMPARATOR
Intervention: Control group (current antidepressant)
Number of subjects: 0
Study 23503737 — intervention group
Group type: EXPERIMENTAL
Intervention: Regent Suit
Number of subjects: 60
Study 20159529 — intervention group
Group type: EXPERIMENTAL
Intervention: Rectally administered indomethacin
Number of subjects: 0
Study 20159529 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 0
Study 19010927 — intervention group
Group type: EXPERIMENTAL
Intervention: Fenretinide (200 mg/daily)
Number of subjects: 235
Study 19010927 — intervention group
Group type: EXPERIMENTAL
Intervention: Low-dose tamoxifen (5 mg/daily)
Number of subjects: 235
Study 19010927 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of fenretinide and tamoxifen
Number of subjects: 235
Study 19010927 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 235
Study 16161398 — intervention group
Group type: EXPERIMENTAL
Intervention: 5th generation bonding system (Optibond Solo)
Number of subjects: 80
Study 16161398 — intervention group
Group type: EXPERIMENTAL
Intervention: 6th generation bonding system (Prompt‐L‐Pop)
Number of subjects: 80
Study 16161398 — intervention group
Group type: EXPERIMENTAL
Intervention: 7th generation bonding system (iBond)
Number of subjects: 80
Study 16161398 — intervention group
Group type: COMPARATOR
Intervention: Control group (no dentinal bonding system)
Number of subjects: 80
Study 12959471 — intervention group
Group type: EXPERIMENTAL
Intervention: Camperdown Program (prolonged-speech treatment model)
Number of subjects: 16
Study 12959471 — intervention group
Group type: EXPERIMENTAL
Intervention: Camperdown Program
Number of subjects: 16
Study 10837289 — intervention group
Group type: EXPERIMENTAL
Intervention: Iron supplementation (20 mg Fe)
Number of subjects: 219
Study 10837289 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 219
Study 8895944 — intervention group
Group type: EXPERIMENTAL
Intervention: Single intravenous administration of 25 mg doxepin
Number of subjects: 15
Study 8895944 — intervention group
Group type: EXPERIMENTAL
Intervention: Three-week open oral treatment with 25 mg doxepin daily
Number of subjects: 15
Study 8895944 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 15
Study 1671471 — intervention group
Group type: EXPERIMENTAL
Intervention: Pump-driven haemofiltration (PDHF)
Number of subjects: 116
Study 1671471 — intervention group
Group type: COMPARATOR
Intervention: Control (CAVH)
Number of subjects: 116
Study 6554617 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedure information
Number of subjects: 111
Study 6554617 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedure and sensation information
Number of subjects: 111
Study 6554617 — intervention group
Group type: EXPERIMENTAL
Intervention: Procedure and sensation information plus information on selected coping strategies
Number of subjects: 111
Study 30678655 — intervention group
Group type: EXPERIMENTAL
Intervention: Trendelenburg position (-15°) as soon as regurgitation was noticed
Number of subjects: 84
Study 30678655 — intervention group
Group type: EXPERIMENTAL
Intervention: Sellick position
Number of subjects: 84
Study 30678655 — intervention group
Group type: COMPARATOR
Intervention: Sniffing position
Number of subjects: 84
Study 28988643 — intervention group
Group type: EXPERIMENTAL
Intervention: Novel fitting algorithm
Number of subjects: 50
Study 28988643 — intervention group
Group type: COMPARATOR
Intervention: Traditional method
Number of subjects: 50
Study 26093810 — intervention group
Group type: EXPERIMENTAL
Intervention: Home exercises (one supervised exercise treatment followed by exercises at home for 6 weeks)
Number of subjects: 46
Study 26093810 — intervention group
Group type: COMPARATOR
Intervention: Supervised exercises (up to 10 supervised exercise treatments in addition to home exercises for 6 weeks)
Number of subjects: 46
Study 26093810 — intervention group
Group type: EXPERIMENTAL
Intervention: Clinical tests of shoulder impingement (part of secondary outcomes)
Number of subjects: 46
Study 23948997 — intervention group
Group type: COMPARATOR
Intervention: Standard daily S‐1 administration (80‐120 mg/day depending on BSA; days 1‐28 every 6 weeks for 1 year)
Number of subjects: 73
Study 23948997 — intervention group
Group type: EXPERIMENTAL
Intervention: Alternate-day S‐1 administration (80‐120 mg/day depending on BSA; alternate days for 15 months)
Number of subjects: 73
Study 21940136 — intervention group
Group type: EXPERIMENTAL
Intervention: Motivational interviewing plus mindfulness meditation (MI-MM)
Number of subjects: 34
Study 21940136 — intervention group
Group type: COMPARATOR
Intervention: Assessment-only control group
Number of subjects: 34
Study 19568216 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive behavioural therapy (CBT) training
Number of subjects: 15
Study 19568216 — intervention group
Group type: COMPARATOR
Intervention: Usual practice (Control)
Number of subjects: 15
Study 16639521 — intervention group
Group type: EXPERIMENTAL
Intervention: Cognitive Behavioral Therapy (CBT)
Number of subjects: 0
Study 12819313 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention (individualized counseling to reduce weight, total and saturated fat intake, and increase fiber intake and physical activity)
Number of subjects: 522
Study 12819313 — intervention group
Group type: COMPARATOR
Intervention: Control group (no lifestyle intervention)
Number of subjects: 522
Study 12819313 — intervention group
Group type: EXPERIMENTAL
Intervention: Lifestyle intervention
Number of subjects: 522
Study 11016525 — intervention group
Group type: EXPERIMENTAL
Intervention: Affective psychosis diagnosis
Number of subjects: 708
Study 11016525 — intervention group
Group type: EXPERIMENTAL
Intervention: Non-affective psychosis diagnosis
Number of subjects: 708
Study 11016525 — intervention group
Group type: EXPERIMENTAL
Intervention: DSM-III-R categories
Number of subjects: 708
Study 11016525 — intervention group
Group type: EXPERIMENTAL
Intervention: ICD-10 categories
Number of subjects: 708
Study 8638999 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal mupirocin ointment (5-day course every month for 1 year)
Number of subjects: 34
Study 8638999 — intervention group
Group type: COMPARATOR
Intervention: Placebo ointment
Number of subjects: 34
Study 8638999 — intervention group
Group type: EXPERIMENTAL
Intervention: Nasal mupirocin ointment
Number of subjects: 34
Study 1386857 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 42 micrograms
Number of subjects: 123
Study 1386857 — intervention group
Group type: EXPERIMENTAL
Intervention: Ipratropium bromide 21 micrograms
Number of subjects: 123
Study 1386857 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 123
Study 6468768 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (5 micrograms X kg‐1 X h‐1)
Number of subjects: 7
Study 6468768 — intervention group
Group type: EXPERIMENTAL
Intervention: Atropine (15 micrograms X kg‐1 X h‐1)
Number of subjects: 7
Study 6468768 — intervention group
Group type: COMPARATOR
Intervention: Cholecystokinin (CCK)
Number of subjects: 7
Study 31483689 — intervention group
Group type: EXPERIMENTAL
Intervention: Somatic yoga and meditation (weekly for 8 weeks, with home program)
Number of subjects: 8
Study 30253712 — intervention group
Group type: EXPERIMENTAL
Intervention: Automated blood pressure self-measurement (BPSM) using a self-measurement station on one arm.
Number of subjects: 80
Study 30253712 — intervention group
Group type: COMPARATOR
Intervention: Office blood pressure measurement (OBPM) performed by clinical staff on both arms.
Number of subjects: 80
Study 27527670 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG 1.5mg as a single dose or in two doses 12h apart, up to 120h of unprotected intercourse
Number of subjects: 6873
Study 27527670 — intervention group
Group type: EXPERIMENTAL
Intervention: LNG 1.5mg
Number of subjects: 6873
Study 26620123 — intervention group
Group type: EXPERIMENTAL
Intervention: Screening arm (PSA measurements scheduled)
Number of subjects: 4276
Study 26620123 — intervention group
Group type: COMPARATOR
Intervention: Control arm (no scheduled PSA measurements)
Number of subjects: 4276
Study 25064681 — intervention group
Group type: EXPERIMENTAL
Intervention: Combination of medication and psychosocial intervention
Number of subjects: 1268
Study 25064681 — intervention group
Group type: COMPARATOR
Intervention: Treatment as usual
Number of subjects: 1268
Study 22892337 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide MMX 9 mg
Number of subjects: 509
Study 22892337 — intervention group
Group type: EXPERIMENTAL
Intervention: Budesonide MMX 6 mg
Number of subjects: 509
Study 22892337 — intervention group
Group type: EXPERIMENTAL
Intervention: Mesalamine 2.4 g
Number of subjects: 509
Study 22892337 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 509
Study 19487135 — intervention group
Group type: EXPERIMENTAL
Intervention: Aspiration plus intra‐articular injection of 3 mL of bupivacaine 0.5%
Number of subjects: 40
Study 19487135 — intervention group
Group type: COMPARATOR
Intervention: Aspiration alone
Number of subjects: 40
Study 17617807 — intervention group
Group type: EXPERIMENTAL
Intervention: Measles vaccine ROUVAX
Number of subjects: 12
Study 17617807 — intervention group
Group type: COMPARATOR
Intervention: Placebo (vehicle)
Number of subjects: 12
Study 15734608 — intervention group
Group type: EXPERIMENTAL
Intervention: Candesartan
Number of subjects: 50
Study 15734608 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 50
Study 12848629 — intervention group
Group type: EXPERIMENTAL
Intervention: 9-month treatment
Number of subjects: 40
Study 12848629 — intervention group
Group type: COMPARATOR
Intervention: 15-month treatment
Number of subjects: 40
Study 10771366 — intervention group
Group type: EXPERIMENTAL
Intervention: Intervention group (I-group)
Number of subjects: 85
Study 10771366 — intervention group
Group type: COMPARATOR
Intervention: Control group
Number of subjects: 85
Study 8876936 — intervention group
Group type: EXPERIMENTAL
Intervention: Fluvastatin
Number of subjects: 8
Study 8876936 — intervention group
Group type: EXPERIMENTAL
Intervention: Bezafibrate
Number of subjects: 8
Study 8876936 — intervention group
Group type: COMPARATOR
Intervention: Diet/Placebo
Number of subjects: 8
Study 1524654 — intervention group
Group type: EXPERIMENTAL
Intervention: Biperiden
Number of subjects: 16
Study 1524654 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 16
Study 6380210 — intervention group
Group type: EXPERIMENTAL
Intervention: Diclofenac 100 mg immediately postoperatively, followed by 50 mg in the evening and 50 mg in the morning after the operation
Number of subjects: 97
Study 6380210 — intervention group
Group type: COMPARATOR
Intervention: Placebo suppositories
Number of subjects: 97
Study 30745277 — intervention group
Group type: EXPERIMENTAL
Intervention: MenAfriVac vaccination in children aged 12–23 months
Number of subjects: 797
Study 30745277 — intervention group
Group type: EXPERIMENTAL
Intervention: MenAfriVac vaccination in participants aged 2–29 years
Number of subjects: 797
Study 30745277 — intervention group
Group type: EXPERIMENTAL
Intervention: MenAfriVac vaccination
Number of subjects: 797
Study 30042225 — intervention group
Group type: EXPERIMENTAL
Intervention: Paclitaxel-coated balloon
Number of subjects: 285
Study 30042225 — intervention group
Group type: COMPARATOR
Intervention: Control balloon (uncoated)
Number of subjects: 285
Study 30042225 — intervention group
Group type: EXPERIMENTAL
Intervention: Both groups
Number of subjects: 285
Study 24926658 — intervention group
Group type: EXPERIMENTAL
Intervention: Social skills intervention
Number of subjects: 92
Study 24926658 — intervention group
Group type: EXPERIMENTAL
Intervention: Playground engagement scores at entry and midpoint of treatment
Number of subjects: 92
Study 23954387 — intervention group
Group type: EXPERIMENTAL
Intervention: Oxiplex/AP gel (Intercoat)
Number of subjects: 52
Study 23954387 — intervention group
Group type: COMPARATOR
Intervention: Control (no gel)
Number of subjects: 52
Study 22011772 — intervention group
Group type: EXPERIMENTAL
Intervention: Mild hypothermic cardiopulmonary bypass (CPB) (Mi > 32 °C, n = 20)
Number of subjects: 40
Study 22011772 — intervention group
Group type: COMPARATOR
Intervention: Moderate hypothermic cardiopulmonary bypass (CPB) (Mo > 26 °C, n = 20)
Number of subjects: 40
Study 20416952 — intervention group
Group type: EXPERIMENTAL
Intervention: Intravitreal bevacizumab (ivB)
Number of subjects: 80
Study 20416952 — intervention group
Group type: COMPARATOR
Intervention: Modified Early Treatment of Diabetic Retinopathy Study (ETDRS) macular laser therapy (MLT)
Number of subjects: 80
Study 18625518 — intervention group
Group type: EXPERIMENTAL
Intervention: Cervical injection
Number of subjects: 54
Study 18625518 — intervention group
Group type: EXPERIMENTAL
Intervention: Hysteroscopic injection
Number of subjects: 54
Study 16143698 — intervention group
Group type: EXPERIMENTAL
Intervention: Clopidogrel (300 mg loading dose, then 75 mg once daily)
Number of subjects: 1863
Study 11845882 — intervention group
Group type: EXPERIMENTAL
Intervention: Standard treatment for heart failure
Number of subjects: 26
Study 11845882 — intervention group
Group type: COMPARATOR
Intervention: Propranolol (additional treatment)
Number of subjects: 26
Study 11845882 — intervention group
Group type: EXPERIMENTAL
Intervention: Group 1 (ICU stay < 7 days)
Number of subjects: 26
Study 11845882 — intervention group
Group type: COMPARATOR
Intervention: Group 2 (ICU stay > 7 days + deaths)
Number of subjects: 26
Study 10429977 — intervention group
Group type: EXPERIMENTAL
Intervention: IL-2 treatment
Number of subjects: 21
Study 7481190 — intervention group
Group type: EXPERIMENTAL
Intervention: Markov chain model for estimating mean sojourn time (MST)
Number of subjects: 0
Study 7481190 — intervention group
Group type: COMPARATOR
Intervention: Traditional method for estimating mean sojourn time
Number of subjects: 0
Study 2115308 — intervention group
Group type: EXPERIMENTAL
Intervention: Metrifonate (10 mg/kg, repeated at 4 month intervals)
Number of subjects: 1813
Study 2115308 — intervention group
Group type: EXPERIMENTAL
Intervention: Praziquantel (1 dose of 40 mg/kg)
Number of subjects: 1813
Study 6108266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam given once daily
Number of subjects: 56
Study 6108266 — intervention group
Group type: COMPARATOR
Intervention: Diazepam given three times a day
Number of subjects: 56
Study 6108266 — intervention group
Group type: EXPERIMENTAL
Intervention: Ketazolam
Number of subjects: 56
Study 6108266 — intervention group
Group type: COMPARATOR
Intervention: Diazepam
Number of subjects: 56
Study 28980034 — intervention group
Group type: EXPERIMENTAL
Intervention: ALA-GLN dipeptide supplementation
Number of subjects: 98
Study 28980034 — intervention group
Group type: COMPARATOR
Intervention: Control (no ALA-GLN dipeptide supplementation)
Number of subjects: 98
Study 28614554 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE) intervention
Number of subjects: 230
Study 28614554 — intervention group
Group type: COMPARATOR
Intervention: Usual Head Start services
Number of subjects: 230
Study 28614554 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE) intervention (lower-level baseline symptoms)
Number of subjects: 230
Study 28614554 — intervention group
Group type: COMPARATOR
Intervention: Usual Head Start services (lower-level baseline symptoms)
Number of subjects: 230
Study 28614554 — intervention group
Group type: EXPERIMENTAL
Intervention: Problem-solving education (PSE) intervention (higher-level baseline symptoms)
Number of subjects: 230
Study 28614554 — intervention group
Group type: COMPARATOR
Intervention: Usual Head Start services (higher-level baseline symptoms)
Number of subjects: 230
Study 26130119 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired left ventricular longitudinal strain (LS) defined as an absolute LS <15.8%
Number of subjects: 447
Study 26130119 — intervention group
Group type: EXPERIMENTAL
Intervention: Impaired left ventricular longitudinal strain (LS)
Number of subjects: 447
Study 26130119 — intervention group
Group type: EXPERIMENTAL
Intervention: Spironolactone
Number of subjects: 447
Study 23249655 — intervention group
Group type: EXPERIMENTAL
Intervention: Iyengar yoga (9-week course)
Number of subjects: 51
Study 23249655 — intervention group
Group type: COMPARATOR
Intervention: Home-based exercise (self-care manual)
Number of subjects: 51
Study 20092985 — intervention group
Group type: EXPERIMENTAL
Intervention: KalmCold (200 mg/day)
Number of subjects: 223
Study 20092985 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 223
Study 18850387 — intervention group
Group type: EXPERIMENTAL
Intervention: Follicular phase premenopausal women
Number of subjects: 81
Study 18850387 — intervention group
Group type: EXPERIMENTAL
Intervention: Oral contraceptive treatment for 2 months (premenopausal women)
Number of subjects: 81
Study 18850387 — intervention group
Group type: EXPERIMENTAL
Intervention: Sequential therapy (postmenopausal women)
Number of subjects: 81
Study 18850387 — intervention group
Group type: COMPARATOR
Intervention: Estrogen-only therapy (postmenopausal women)
Number of subjects: 81
Study 18850387 — intervention group
Group type: EXPERIMENTAL
Intervention: Smokers
Number of subjects: 81
Study 16897235 — intervention group
Group type: COMPARATOR
Intervention: Propofol alone (group P)
Number of subjects: 16
Study 16897235 — intervention group
Group type: EXPERIMENTAL
Intervention: 66% nitrous oxide with propofol (group PN)
Number of subjects: 16
Study 14535021 — intervention group
Group type: EXPERIMENTAL
Intervention: 654‐2 injection and 'Gan Xian Tui Huang Recipe'
Number of subjects: 60
Study 14535021 — intervention group
Group type: COMPARATOR
Intervention: Routine treatment (Control)
Number of subjects: 60
Study 10913808 — intervention group
Group type: EXPERIMENTAL
Intervention: Therapy A
Number of subjects: 0
Study 10913808 — intervention group
Group type: COMPARATOR
Intervention: Therapy B
Number of subjects: 0
Study 8775240 — intervention group
Group type: EXPERIMENTAL
Intervention: Intraumbilical 20 IU of oxytocin diluted to 40 mL with saline
Number of subjects: 72
Study 8775240 — intervention group
Group type: COMPARATOR
Intervention: Intraumbilical vein 40 mL of saline
Number of subjects: 72
Study 8775240 — intervention group
Group type: COMPARATOR
Intervention: Standard protocol without any intraumbilical injection
Number of subjects: 72
Study 1290181 — intervention group
Group type: EXPERIMENTAL
Intervention: Pulsatile perfusion
Number of subjects: 80
Study 1290181 — intervention group
Group type: COMPARATOR
Intervention: Nonpulsatile perfusion
Number of subjects: 80
Study 6463852 — intervention group
Group type: EXPERIMENTAL
Intervention: Vitrectomy for chronic aphakic cystoid macular edema
Number of subjects: 130
Study 6463852 — intervention group
Group type: COMPARATOR
Intervention: Control group (not specified)
Number of subjects: 130
Study 31561398 — intervention group
Group type: EXPERIMENTAL
Intervention: Dance Group (DG)
Number of subjects: 33
Study 31561398 — intervention group
Group type: COMPARATOR
Intervention: Control Group (CG)
Number of subjects: 33
Study 29351790 — intervention group
Group type: EXPERIMENTAL
Intervention: QuinteT Recruitment Intervention (QRI)
Number of subjects: 8
Study 27462065 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-assisted quality improvement (QI) intervention
Number of subjects: 577
Study 27462065 — intervention group
Group type: COMPARATOR
Intervention: Control condition
Number of subjects: 577
Study 27462065 — intervention group
Group type: EXPERIMENTAL
Intervention: Technology-assisted QI intervention
Number of subjects: 577
Study 24103017 — intervention group
Group type: EXPERIMENTAL
Intervention: Imiquimod treatment
Number of subjects: 20
Study 24103017 — intervention group
Group type: EXPERIMENTAL
Intervention: Optical coherence tomography (OCT) imaging
Number of subjects: 20
Study 22551036 — intervention group
Group type: EXPERIMENTAL
Intervention: Naltrexone
Number of subjects: 265
Study 22551036 — intervention group
Group type: COMPARATOR
Intervention: Placebo
Number of subjects: 265